Vise Technologies’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-8,088
Closed -$2.84M – 1879
2026
Q1
$2.84M Hold
8,088
– – 0.06% 271
2025
Q4
$2.84M Buy
8,088
+1,359
+20% +$459K 0.06% 272
2025
Q3
$2.17M Buy
6,729
+834
+14% +$259K 0.08% 237
2025
Q2
$2.29M Buy
+5,895
New +$2.37M 0.09% 225
2024
Q4
$1.09M Buy
2,947
+830
+39% +$347K 0.09% 231
2024
Q3
$1.1M Buy
2,117
+484
+30% +$259K 0.14% 146
2024
Q2
$885K Buy
1,633
+127
+8% +$67.1K 0.16% 136
2024
Q1
$781K Sell
1,506
-252
-14% -$125K 0.15% 140
2023
Q4
$829K Buy
1,758
+7
+0.4% +$3.24K 0.18% 127
2023
Q3
$762K Buy
1,751
+186
+12% +$84.4K 0.19% 121
2023
Q2
$695K Buy
1,565
+174
+13% +$80.3K 0.17% 134
2023
Q1
$640K Buy
1,391
+381
+38% +$181K 0.17% 138
2022
Q4
$518K Buy
1,010
+25
+3% +$12.7K 0.16% 143
2022
Q3
$447K Buy
985
+354
+56% +$169K 0.17% 143
2022
Q2
$305K Buy
631
+87
+16% +$43K 0.12% 195
2022
Q1
$267K Buy
+544
New +$249K 0.1% 188

Other funds holding ELV

Vise Technologies's ELV Position: Q2 2026 in Review

Vise Technologies sold out of Elevance Health (ELV) in Q2 2026, closing a stake of 8,088 shares — an estimated $2.84M sold.

Vise Technologies first reported a position in ELV in Q1 2022 and held it in 16 quarters. The position peaked at $2.84M in Q1 2026. 1,612 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Vise Technologies reported no remaining Elevance Health position as of Q2 2026 after selling out during the quarter.
  • Vise Technologies sold 8,088 Elevance Health shares in Q2 2026, an estimated $2.84M.
  • Vise Technologies first reported a position in Elevance Health in Q1 2022 and held it in 16 quarters.
  • Vise Technologies's Elevance Health position peaked at $2.84M in Q1 2026.
  • 1,612 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Vise Technologies's 13F filing for Q2 2026, filed 11 Aug 2026.